Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Learning to manage meds could shield kidneys

NCT ID NCT07622134

First seen Jun 04, 2026 · Last updated Jun 23, 2026 · Updated 2 times

Summary

This study tests an 8-week health literacy program designed to help people aged 55-74 who take five or more daily medications prevent chronic kidney disease. The program teaches skills like medication management, healthy eating, and physical activity. Researchers will compare health literacy and kidney function between those who take the program and those who receive standard care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTH LITERACY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Health Promoting Hospital

    Nakhon Pathom, Changwat Nakhon Pathom, 73000, Thailand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Health Literacy Promotion Program (HLP-CKD) - an 8-week behavioral program with education and skill-building for medication management

What this could lead to

If it works, this program could help people taking many medications better manage their health and lower their risk of developing chronic kidney disease.

What could go wrong

This is a small, early-stage study with only 104 participants, so results may not apply to everyone. The program relies on behavior change, which can be hard to maintain long-term.

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.